Staten Island University Hospital is a member hospital of Northwell Health. It is a major tertiary referral center in Staten Island, New York City. SIUH is a two-campus, 668-bed specialized teaching hospital.

There are 668 beds in Staten Island University Hospital.

During the past decade, Staten Island University Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 47 clinical trials were completed, i.e. on average, 102.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 22 clinical trials were completed. i.e. 129.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Staten Island University Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Northwell Health" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "Boston Scientific Corporation" with 5 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Staten Island University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Staten Island University Hospital" with 10 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Staten Island University Hospital" are "Breast Cancer" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "HER2/Neu Negative" (5 trials), "Invasive Breast Carcinoma" (5 trials) and "Stage IIIA Breast Cancer" (5 trials). Many other conditions were trialed in "Staten Island University Hospital" in a lesser frequency.

Most popular intervention types in "Staten Island University Hospital" are "Drug" (69 trials), "Other" (47 trials), "Biological" (22 trials), "Device" (19 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Paclitaxel" (15 trials), "Quality-of-Life Assessment" (15 trials), "Bevacizumab" (11 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Staten Island University Hospital" are 104 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Staten Island University Hospital". undefined are not yet recruiting, 14 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in Staten Island University Hospital, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Staten Island University Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".